Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
0.00%
)
US TECH 100
26,368.00
(
1.19%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
99.75
(
-1.44%
)
Bitcoin
78,381.05
(
0.13%
)
News Focus
News Focus
Post# of 38634
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

doogdilinger

Send PM Follow Ignore
Followers 3163
Posts 209639
Boards Moderated 1
Alias Born 02/04/2004

doogdilinger

Member Level

Re: doogdilinger post# 30456

Tuesday, 10/10/2017 8:26:52 PM

Tuesday, October 10, 2017 8:26:52 PM

Post# of 38634
Just over $20M PAR/FocalinXR sales during IPCI's fiscal Q2...and just over $17M PAR/FocalinXR sales during IPCI's fiscal Q3...yet IPCI's actual reported revenues came nowhere close to matching those reported Q3 PAR/FocalinXR sales numbers from Bloomberg...meaning the Bloomberg numbers were wrong...or IPCI just had their PAR/FocalinXR profit sharing licensing deal terms changed to a drastically reduced level after their fiscal Q2 earnings without informing anyone lol.


Never buy or sell based on my posts! My posts are just my opinion!

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote